Skip to content

Application of erythropoietin in enriched bone marrow stem cells technique to promote bone regeneration

Application of erythropoietin in enriched bone marrow stem cells technique to promote bone regeneration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012403
Enrollment
Unknown
Registered
2017-08-17
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bone defect, bone non-union and lumber spinal stenosis

Interventions

treatment group:administer erythropoietin (150U/kg) three to five times via subcutaneous or intravenous injection before operation
controlled group:administer normal saline three times via subcutaneous or intravenous injection before operation

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Aged from 30 to 65 years, male and female; (2) the patients who suffer from bone un-union, bone defect or two or three segmental lumber spine disease requiring decompression surgery and intervertebral fusion; (3) Be willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. malignant or benign tumor; 2. polycythemia vera; 3. myelodysplastic syndrome; 4. infected disease; 5. high dose chemoradiotherapy; 6. blood system disease; 7. operation site with infection or Hemoculture positive recently; 8. Hb10 seconds and platelet less than 60×10^9/L 9. pregnant woman; 10. patients with decompensated cirrhosis,uremia or severe brain trauma; 11. patient paticipating in other clinial trials in the same time.

Design outcomes

Primary

MeasureTime frame
clinical union time;the amount of bone marrow stem cells;

Secondary

MeasureTime frame
the amount of bone callus;

Countries

China

Contacts

Public ContactYaoKai Gan

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine

ganyk2004@126.com+86 15021317328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026